Dashboard
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Net Sales has grown by an annual rate of -9.13% and Operating profit at -191.46% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
HKD 23,843 Million ()
21,821.00
NA
0.00%
-0.44
-999,999.00%
8.65
Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Mar 2012)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
87.07%
0%
87.07%
6 Months
325.04%
0%
325.04%
1 Year
396.39%
0%
396.39%
2 Years
935.78%
0%
935.78%
3 Years
1075.21%
0%
1075.21%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Shanghai Conant Optical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-9.13%
EBIT Growth (5y)
-191.46%
EBIT to Interest (avg)
-0.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
1.96
Tax Ratio
26.17%
Dividend Payout Ratio
27.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
21821
Industry P/E
Price to Book Value
8.40
EV to EBIT
-9482.01
EV to EBITDA
-14621.25
EV to Capital Employed
14.27
EV to Sales
1407.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.15%
ROE (Latest)
0.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'12 - YoY
Mar'12
Mar'11
Change(%)
Net Sales
3.70
4.00
-7.50%
Operating Profit (PBDIT) excl Other Income
-0.40
-0.40
Interest
0.50
0.70
-28.57%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.70
0.80
-12.50%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2012 is -7.50% vs -9.09% in Mar 2011
Consolidated Net Profit
YoY Growth in quarter ended Mar 2012 is -12.50% vs 100.00% in Mar 2011
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
1,944.40
1,815.60
7.09%
Operating Profit (PBDIT) excl Other Income
483.70
409.60
18.09%
Interest
15.10
29.90
-49.50%
Exceptional Items
-7.60
0.60
-1,366.67%
Consolidate Net Profit
361.40
289.10
25.01%
Operating Profit Margin (Excl OI)
215.90%
195.90%
2.00%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 7.09% vs 11.09% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 25.01% vs 30.70% in Dec 2022
About Shanghai Conant Optical Co., Ltd. 
Shanghai Conant Optical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






